PTGX Stock Ownership Activity

PROTAGONIST THERAPEUTICS INC 13F holders

1 value investing guru has made changes to the PROTAGONIST THERAPEUTICS INC (PTGX) position according to the gurus' latest SEC quarterly report(s). The number of PTGX shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying PTGX now?

According to the latest SEC filing(s) PROTAGONIST THERAPEUTICS INC (PTGX) has been bought by David M. Polen - Polen Capital Management (added shares +19.6%).

To see more about who is investing in PROTAGONIST THERAPEUTICS INC (PTGX), please go to the PTGX ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2026 Q1 (1 result)
David M. Polen
Polen Capital Management
+19.60%
+3,988
+0.00%
0.02%
Current price: $95.41 9.48% Reported price*: $105.40
2025 Q4 (1 result)
David M. Polen
Polen Capital Management
+0.12%
+24
+0.00%
0.01%
Current price: $95.41 9.24% Reported price*: $87.34
2025 Q3 (1 result)
David M. Polen
Polen Capital Management
+27.04%
+4,326
+0.00%
0.00%
Current price: $95.41 43.62% Reported price*: $66.43
2025 Q2 (1 result)
David M. Polen
Polen Capital Management
buy
+15,999
+0.00%
0.00%
Current price: $95.41 72.63% Reported price*: $55.27
4 of 4

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.